Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

MERCK AND COMPANY

(MRK)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/10/2019 06/11/2019 06/12/2019 06/13/2019 06/14/2019 Date
82.48(c) 82.98(c) 83.71(c) 82.9(c) 82.78(c) Last
7 191 129 7 432 946 10 551 351 9 727 147 7 045 373 Volume
+0.02% +0.61% +0.88% -0.97% -0.14% Change
More quotes
Financials (USD)
Sales 2019 44 739 M
EBIT 2019 15 043 M
Net income 2019 10 688 M
Debt 2019 17 003 M
Yield 2019 2,67%
Sales 2020 47 332 M
EBIT 2020 16 511 M
Net income 2020 12 239 M
Debt 2020 13 778 M
Yield 2020 2,77%
P/E ratio 2019 19,85
P/E ratio 2020 17,15
EV / Sales2019 5,13x
EV / Sales2020 4,78x
Capitalization 212 B
More Financials
Company
Merck and Company specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (73.4%): for treating hypertension, osteoporosis, atherosclerosis, respiratory,... 
Sector
Pharmaceuticals
Calendar
06/14Ex-dividend day for
More about the company
Surperformance© ratings of Merck and Company
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK AND COMPANY
02:48aDrug Firms Sue Over Ad Rule -- WSJ
DJ
06/14Drugmakers Sue to Block Federal Rule Requiring Drug Prices in TV Ads
DJ
06/14MERCK AND : Provides Comment on Federal Lawsuit Challenging New Requirements in ..
PU
06/14MERCK AND COMPANY : Ex-dividend day for
FA
06/13MERCK AND : IBM, KPMG, Merck and Walmart to collaborate as part of FDA's program..
PU
06/13MERCK AND : Pembro Now Approved for First-Line Use in Head and Neck Cancer
AQ
06/12MERCK AND : The Foundation of Merck & Co., Inc., Kenilworth, NJ, USA Announces G..
AQ
06/12MERCK AND : The Foundation of Merck & Co., Inc., Kenilworth, NJ, USA Announces G..
AQ
06/12MERCK AND : FDA Approves Two New Indications for Mercks KEYTRUDA (pembrolizumab)
AQ
06/11THE DAILY MACRO BRIEF : Amazon, Google, Merck, Airbus…
More news
Analyst Recommendations on MERCK AND COMPANY
More recommendations
Sector news : Pharmaceuticals - NEC
02:48aDrug Firms Sue Over Ad Rule -- WSJ
DJ
06/14Drugmakers Sue to Block Federal Rule Requiring Drug Prices in TV Ads
DJ
06/14BAYER : to Invest Billions in Weedkillers in Wake of Roundup Controversy--Update
DJ
06/14BAYER : Deutsche Bahn to Phase out Glyphosate -WirtschaftWoche
DJ
06/14BAYER : to Invest Billions in Weedkillers in Wake of Roundup Controversy
DJ
More sector news : Pharmaceuticals - NEC
Chart MERCK AND COMPANY
Duration : Period :
Merck and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 88,9 $
Spread / Average Target 7,9%
EPS Revisions
Managers
NameTitle
Kenneth C. Frazier Chairman, President & Chief Executive Officer
Robert M. Davis CFO & Executive Vice President-Global Services
Sandy Tremps Vice President-R&D IT CIO
James H. Scholefield Chief Information & Digital Officer
Thomas Henry Glocer Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MERCK AND COMPANY8.34%206 641
JOHNSON & JOHNSON9.04%348 981
PFIZER-2.63%233 072
ROCHE HOLDING LTD.13.39%227 848
NOVARTIS20.35%220 893
ELI LILLY AND COMPANY-3.44%113 364